Daniel Fero
InvestorManaging Director at OMX Ventures
Boston, Massachusetts
Writes $500K β $15M checks Β· typically $7.8M
About
Dan Fero is a co-founder and managing partner at OMX Ventures, focusing on platform companies that use a data-driven approach to product discovery and development, and supporting founders turning scientific discoveries into products. He previously was a venture investor at Merieux Equity Partners and a strategy consultant at L.E.K. Consulting in Boston, and co-founded the precision oncology company Uereka Biosciences. He holds a PhD in Biomedical Sciences from UCSD and a BA in biology from Rhode Island College.
Matterworks @matterworks_bio
https://t.co/2GSSMxtM09
Apr 20, 2026 Β· β₯ 1
Matterworks @matterworks_bio
We found a previously unreported biomarker in one of the best annotated lipidomics datasets in the public domain! The lipid was PC 32:3. It's been a fixture of commercial targeted lipidomics panels for years, with a steady accumulation of evidence tying it to insulin resistance
Apr 20, 2026 Β· β₯ 2
Matterworks @matterworks_bio
Two public studies are pre-loaded for exploration (Antipsychotic Overdose, Cystic Fibrosis), and you can upload your own. Try it: https://t.co/Zs0LnEJaJQ
Oct 31, 2025 Β· β₯ 3 Β· β 1
Invests in
BiotechDeep TechHealthtech
Investments
Investor
CellsonicsMatterworksMythic TherapeuticsReAx BiotechnologiesType6 Therapeutics
Per the firm's website.
Colleagues at OMX Ventures
Network3
Investors connected to Daniel in public investor directories β a warm-intro map.